Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

29.07 -0.12 (-0.43%)
Streaming Delayed Price Updated: 12:05 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,060,443
Open 29.21
Bid (Size) 29.07 (62)
Ask (Size) 29.08 (40)
Prev. Close 29.20
Today's Range 29.07 - 29.49
52wk Range 25.20 - 33.92
Shares Outstanding 5,606,688,356
Dividend Yield 5.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fifth Avenue Animate Launches New Website to Highlight Expertise in SaaS and Finance Video Marketing
Mississauga, Ontario () October 8, 2024 -- Agency continues to deliver high-impact animated content, helping businesses explain complex concepts and drive customer engagement. 
Via Prodigy
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets

Performance

YTD
-2.20%
-2.20%
1 Month
-1.14%
-1.14%
3 Month
+4.10%
+4.10%
6 Month
+9.39%
+9.39%
1 Year
-12.42%
-12.42%

More News

Read More
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Starboard Value Reportedly Acquires $1B Stake In Pfizer As Stock Lags S&P 500 By 46%
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Pfizer Stock Popped on Monday
Via The Motley Fool
Behind the Scenes of Pfizer's Latest Options Trends
Via Benzinga
Key Takeaways From Pfizer Analyst Ratings
Via Benzinga
Pfizer Stock Is Moving Higher Monday: What's Driving The Action?
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
Via Investor's Business Daily
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Via MarketBeat
Exposures COVID-19 Product Safety
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Via Benzinga
Exposures COVID-19
Wall Street Set To Start New Week Sharply Lower As Traders Brace For Key Economic Data And Fed Minutes: Why Strategist Sees Market Consolidating In Near Term
Via Benzinga
Topics Economy
Exposures Interest Rates
Amid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report
Via Benzinga
Exposures COVID-19
3 High-Yield Dividend Stocks That Are Screaming Buys Right Now
Via The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
Via The Motley Fool
Want Over $5,000 in Annual Dividends? Invest $23,000 in Each of These 3 Stocks
Via The Motley Fool
Election Outcome Presents Opportunity For Investors
Via Talk Markets
Topics Government
Exposures Political
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Via Investor's Business Daily
3 Top Stocks That Could Still Rocket Higher in 2024
Via The Motley Fool
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Via Benzinga
3 Stocks Set to Benefit from Cooling Inflation Trends
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Is Pfizer a Buy Right Now or a Value Trap?
Via The Motley Fool
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
Via Benzinga
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.